A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and, if proven effective, will offer an inexpensive option for the treatment of early MS. Clinical researchers in Calgary
Read More...
Attachment(s): MSConnectionsDec07.pdf